Skip to main content
. 2013 Feb 15;8(2):e56745. doi: 10.1371/journal.pone.0056745

Table 2. Clinical and hematological characteristics of population with NLR≤3.95 and NLR>3.95.

NLR≤3.95 NLR>3.95 P-value
n 1441 680
Age in years, median (25th–75th percentile) 63.5(53–73) 72(62–80) <0.001
Men, n(%) 856(59.4) 400(58.7) 0.8
BMI in kg/m2, median (25th–75th percentile) 26(24–29) 25(23–28) 0.2
Hypertension, n(%) 1170(81.1) 557(81.8) 0.8
Type 2 diabetes, n(%) 442(30.7) 278(40.8) <0.001
Prior myocardial infarction, n(%) 47(3.3) 48(7.0) <0.001
Atrial fibrillation, n(%) 189(13.1) 184(27.0) <0.001
TIA, prior stroke, n(%) 98(6.8) 73(10.7) 0.003
Congestive heart failure, n(%) 99(6.9) 103(15.1) <0.001
Coronary artery disease, n(%) 468(32.5) 284(41.7) <0.001
Cerebrovascular arterial disease, n(%) 988(68.5) 478(70.2) 0.6
Critical limb ischemia, n(%) 350(24.3) 330(48.5) <0.001
CRP in mg/l, median (25th–75th percentile) 3(1.5–5.5) 5.6(2.3–19.1) <0.001
Fibrinogen in mg/dl, median (25th–75th percentile) 344(308–403.5) 412(345.5–507.5) <0.001
Platelets in 1000/µl, median (25th–75th percentile) 228(192–273) 232(191.3–295.8) 0.1
NLR, median (25th–75th percentile) 2.56(2.05–3.19) 5.6(4.95–7.87) <0.001